Clinical trials and data disclosure

The Academy is responding to the House of Commons Science and Technology Committee's inquiry into clinical trials and disclosure of data

The inquiry includes questions about the proposed European Clinical Trials Regulation; the role of the new Health Research Authority (HRA); and the debate about the transparency of clinical trial data. 

The response will be available online once the House of Commons has published the evidence.

The President's thoughts have been compiled and sent to the Fellowship to inform them of the situation, and they are available to download from this page.

Addressing antimicrobial resistance with a One Health approach invite-only symposium and workshop

Book Now

2024 FORUM Sir Colin Dollery Lecture: Health research where you are – from GP to care home

Book Now

Mentoring Masterclass - June 2024

Book Now
View more
FB Twitter Instagram Youtube